查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840267

2025年全球医疗保健奈米技术市场报告

Healthcare Nanotechnology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，医疗保健奈米技术市场发展迅速，预计从2024年的3,442.3亿美元成长到2025年的3,860.1亿美元，复合年增长率达12.1%。过去一段时间的成长可归因于奈米材料、奈米医学研究、监管支持、研发投资和奈米结构生物材料的进步。

预计未来几年，医疗保健奈米技术市场将快速成长，到2029年市场规模将达到7,078.1亿美元，复合年增长率（CAGR）为16.4%。预测期内的成长可归因于治疗诊断学、基因治疗奈米颗粒、生物相容性奈米材料、奈米手术器械、奈米级疗法以及全球卫生应急准备等领域的进展。预测期内的关键趋势包括诊断奈米设备、生物感测器和成像、奈米机器人和奈米手术、个人化医疗以及公众意识和教育。

医疗奈米技术是指将奈米技术与药物和诊断分子结合，以改善特定细胞和组织功能的科学领域。这些材料在奈米尺度上製造，可安全注射到体内。奈米技术能够显着改善医疗诊断，使其更经济、更便利。

医疗奈米技术主要分为有机奈米技术、无机奈米技术和碳基奈米技术。医疗奈米技术应用于多种疾病的治疗，包括循环系统、肿瘤、神经系统疾病、整形外科和感染疾病。其主要应用领域包括药物传递、生医材料、活性植入和组织再生。

美国在2025年春季突然提高关税及其引发的贸易摩擦，对资讯科技产业，特别是硬体製造、资料基础设施和软体部署领域，产生了重大影响。进口半导体、电路基板和网路设备的关税上涨，推高了高科技公司、云端服务供应商和资料中心的生产和营运成本。在全球范围内采购笔记型电脑、伺服器和消费电子产品零件的公司，面临更长的前置作业时间和价格压力。同时，对专用软体征收的关税以及主要国际市场的报復性措施，扰乱了全球IT供应链，并降低了海外对美国製造技术的需求。为了应对这些挑战，该产业正在加大对国内晶片生产的投资，扩大供应商网络，并利用人工智慧驱动的自动化技术来增强韧性，更有效地控製成本。

本研究报告是商业研究公司（The Business Research Company）全新系列报告的一部分，提供医疗保健奈米技术市场统计数据，例如全球医疗保健奈米技术行业市场规模、区域份额、竞争对手及其市场份额、详细的医疗保健奈米技术市场细分、市场趋势和商业机会，为您提供在医疗保健奈米技术行业取得成功所需的数据。本医疗保健奈米技术市场研究报告透过对产业现状和未来发展趋势的详细分析，为您提供所需的一切观点。

未来五年16.4%的预测成长率较我们先前对该市场的预测略微下降0.4%。这一下降主要归因于美国与其他国家之间的关税影响。由于关税推高了来自亚洲和欧洲的稀有精密奈米材料的成本，美国奈米技术和医疗保健市场的创新速度可能会放缓。此外，相互关税以及日益加剧的贸易紧张局势和限制措施对全球经济和贸易造成的负面影响也将影响更广泛的领域。

癌症发病率的上升预计将推动医疗奈米技术市场的成长。奈米技术是一种很有前景的癌症治疗方法，有望为包括癌症在内的多种疾病提供更个人化的治疗。全球癌症发生率持续上升。例如，美国癌症协会估计，到2023年，美国将新增1,958,310例癌症病例，并有609,820例癌症相关死亡病例。儘管医疗技术和早期检测方法取得了进步，但这些统计数据凸显了癌症预防和治疗方面仍面临的持续挑战。这些数据强调了继续进行研究和製定有效医疗保健策略以有效对抗癌症的迫切需求。因此，癌症患者数量的增加正在推动医疗奈米技术市场的成长。

糖尿病和肥胖症的日益普及预计将推动医疗奈米技术市场的未来成长。糖尿病是指血糖值过高所引起的疾病，而肥胖症是指肥胖指数达到或超过30。医疗奈米技术提供标靶药物传递和精准医疗方法，用于控製糖尿病和肥胖症，在提高治疗效果的同时最大限度地减少副作用。例如，据总部位于比利时的国际糖尿病联盟（IDF）称，到2022年6月，全球糖尿病盛行率将上升至10.5%，其中超过一半（44.7%）的患者仍未被确诊。 IDF预测，到2045年，将有7.83亿人（即八分之一的成年人）患有糖尿病。这将比同期预期的人口成长率（20%）高出46%以上。此外，据总部位于瑞士的世界卫生组织（WHO）称，到2022年3月，将有6.5亿成年人、3.4亿青少年和3,900万名儿童患有肥胖症。世界卫生组织预测，到2025年，将有1.67亿成年人和儿童超重或肥胖。因此，糖尿病和肥胖症的增加正在推动医疗保健奈米技术市场的成长。

企业间的策略合作是医疗保健奈米技术市场日益流行的主要趋势。从事医疗保健奈米技术的公司正在建立联盟和伙伴关係，以开发新技术和产品。 2022年1月，总部位于美国的医疗保健相关企业NaNotics与梅奥诊所合作开发一种名为NaNots的癌症治疗方法。在此次合作中，NaNotics将与梅奥诊所的研究人员共用其奈米耗竭平台，而梅奥诊所将提供其专有的PD-L1抗体和可递送人源sPD-L1的基因转殖小鼠模型。梅奥诊所是一家总部位于美国的医疗机构，致力于在包括奈米医学在内的多个医学领域进行病患治疗、教育和研究。

医疗奈米技术市场涵盖了肿瘤标靶化、药物传输系统和改进型医学成像营业单位所产生的收入。市场价值包括服务提供者销售的相关商品或包含在服务产品中的商品价值。仅包括营业单位间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球医疗奈米技术：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 终端用户产业分析
  • 全球医疗奈米技术市场：成长率分析
  • 全球医疗保健奈米技术市场表现：规模与成长，2019-2024年
  • 全球医疗保健奈米技术市场预测：规模与成长，2024-2029年，2034年
  • 全球医疗保健奈米技术：潜在市场规模 (TAM)

第六章 市场细分

  • 全球医疗保健奈米技术市场：按疾病、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 心血管疾病
  • 肿瘤性疾病
  • 神经系统疾病
  • 整形外科疾病
  • 感染疾病
  • 全球医疗保健奈米技术市场：按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 有机的
  • 无机物
  • 碳基
  • 全球医疗保健奈米技术市场：按应用、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 药物递送
  • 生物材料
  • 主动植入
  • 组织再生
  • 全球医疗保健奈米技术市场：按心血管疾病类型细分、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 药物输送系统
  • 诊断影像
  • 全球医疗保健奈米技术市场：按肿瘤疾病（按类型）细分、性能和预测，2019-2024年、2024-2029年、2034年
  • 标靶药物递送
  • 基于奈米颗粒的治疗方法
  • 影像诊断
  • 全球医疗奈米技术市场：按神经系统疾病类型细分、性能和预测（2019-2024年、2024-2029年、2034年）
  • 基于奈米颗粒的药物递送
  • 诊断工具
  • 全球医疗奈米技术市场：按整形外科疾病类型细分、性能和预测（2019-2024年、2024-2029年、2034年）
  • 骨再生与修復
  • 药物输送系统
  • 全球医疗保健奈米技术市场：按感染疾病类型细分、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 抗菌奈米材料
  • 疫苗输送系统

第七章 区域和国家分析

  • 全球医疗保健奈米技术市场：按地区、绩效和预测划分，2019-2024年、2024-2029年、2034年
  • 全球医疗保健奈米技术市场：按国家/地区、绩效和预测划分，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 医疗保健奈米技术市场：竞争格局
  • 医疗保健奈米技术市场：公司概况
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Teva Pharmaceutical Industries Ltd.
  • Sanofi SA
  • Taiwan Liposome Company Ltd.
  • GE Healthcare Technologies Inc.
  • Mallinckrodt plc
  • Leadiant Biosciences
  • Luminex Corporation
  • Bristol-Myers Squibb Company
  • CytImmune Sciences Inc.
  • Nanobiotix
  • Starpharma Holdings Limited
  • Copernicus Therapeutics Inc.
  • NanoCarrier Co. Ltd
  • LiPlasome Pharma ApS
  • Nami Therapeutics Corp.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年医疗保健奈米技术市场：提供新机会的国家
  • 2029年医疗保健奈米技术市场：新兴细分市场机会
  • 2029年医疗保健奈米技术市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r21584u

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical.

The main types of healthcare nanotechnology include organic, inorganic, and carbon-based. Healthcare nanotechnology is used for various diseases such as cardiovascular, oncological, neurological, orthopedic, and infectious diseases. The main applications of healthcare nanotechnology include drug delivery, biomaterials, active implants, and tissue regeneration.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The healthcare nanotechnology market research report is one of a series of new reports from The Business Research Company that provides healthcare nanotechnology market statistics, including healthcare nanotechnology industry global market size, regional shares, competitors with healthcare nanotechnology market share, detailed healthcare nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare nanotechnology industry. This healthcare nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare nanotechnology market size has grown rapidly in recent years. It will grow from $344.23 billion in 2024 to $386.01 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to advancements in nanomaterials, nanomedicine research, regulatory support, investment in research and development, nanostructured biomaterials.

The healthcare nanotechnology market size is expected to see rapid growth in the next few years. It will grow to $707.81 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to theranostics development, nanoparticles for gene therapy, biocompatible nanomaterials, nano-enabled surgical tools, nanoscale therapeutic agents, global health emergency preparedness. Major trends in the forecast period include diagnostic nanodevices, biosensors and imaging, nanorobotics and nanosurgery, personalized medicine, public awareness and education therapeutic applications.

The forecast of 16.4% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. nanotech healthcare market may face innovation delays as tariffs increase the cost of rare and precision-engineered nanomaterials from Asia and Europe. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cancer cases is anticipated to drive the growth of the healthcare nanotechnology market. Nanotechnology represents a promising approach to cancer treatment, offering the potential for more personalized therapies for various diseases, including cancer. The global prevalence of cancer continues to rise. For example, in 2023, the American Cancer Society estimated that there would be 1,958,310 new cancer diagnoses and 609,820 cancer-related deaths in the United States. These statistics underscore the persistent challenges in cancer prevention and treatment, despite advancements in medical technology and early detection methods. They highlight the urgent need for ongoing research and effective healthcare strategies to address cancer effectively. Consequently, the increasing number of cancer cases is fueling the growth of the healthcare nanotechnology market.

Growing incidences of diabetes and obesity are expected to propel the growth of the healthcare nanotechnology market going forward. Diabetes refers to a condition that develops when blood glucose levels are too high, and obesity refers to the condition of having a body mass index of 30 or more. Healthcare nanotechnology offers targeted drug delivery and precision medicine approaches to manage diabetes and obesity, improving treatment efficacy while minimizing side effects. For instance, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10. 5% worldwide, with over half (44. 7%) of people still undiagnosed. According to IDF predictions, 783 million adults, or one in eight people, will have diabetes by 2045. This would represent a 46% rise, more than double the projected population growth for the same period (20%). Furthermore, in March 2022, according to the World Health Organization, a Switzerland-based agency, 650 million adults, 340 million teenagers, and 39 million children will be obese. This quantity is still rising, and the WHO predicts that by 2025, 167 million adults and children will become overweight or obese. Therefore, growing incidences of diabetes and obesity are driving the growth of the healthcare nanotechnology market.

Strategic collaboration between companies is a key trend gaining popularity in the healthcare nanotechnology market. Companies involved in healthcare nanotechnologies are undergoing partnerships and collaboration to develop new technologies and products. In January 2022, NaNotics, a US-based medical company, collaborated with the Mayo Clinic to develop a cancer treatment known as NaNots. The collaboration will involve NaNotics sharing its nano-depletion platform with Mayo researchers, while the Mayo Clinic will provide its own PD-L1 antibody and a transgenic mouse model that provides human sPD-L1. Mayo Clinic is a US-based clinic dedicated to providing patient care, education, and research in various fields of medicine, including nanomedicine.

Major companies operating in the healthcare nanotechnology market are increasing their focus on introducing nanotechnology-based gel serums to gain a competitive edge in the market. Nanotechnology-based gel serums are products that incorporate nanoscale particles or delivery systems to enhance the absorption and effectiveness of active ingredients. For instance, in March 2023, ENTOD Pharmaceuticals, an India-based healthcare company, launched Eyecirque, a nanotechnology-based under-eye product, in India. Eyecirque is formulated with a cutting-edge, 100% plant-based biocellular composition, featuring vitamin A, C, and E complexes, anti-aging antioxidants, skin-brightening agents, and naturally occurring ultra-moisturizing elements that are rapidly absorbed into the skin around the eyes at a nano-molecular level. It stands as the world's first gel serum of its kind, utilizing nanotechnology to address concerns such as wrinkles, hollowness, hollow eyelids, and dark circles under the eyes.

In January 2024, GenEdit, Inc., a US-based biotechnology firm, announced a multiyear collaboration and licensing agreement with Genentech to develop innovative nanoparticles for the delivery of genetic medicines intended to treat autoimmune diseases. This partnership will utilize GenEdit's NanoGalaxy platform, emphasizing the discovery of hydrophilic nanoparticles (HNPs) for nucleic acid-based therapies. Genentech, also based in the US, is a biotechnology corporation that specializes in healthcare nanotechnology.

Major companies operating in the healthcare nanotechnology market include Pfizer Inc., Johnson & Johnson Inc., Abbott Laboratories, Merck & Company Inc., Union Chimique Belge S. A, Teva Pharmaceutical Industries Ltd., Sanofi SA, Taiwan Liposome Company Ltd., GE Healthcare Technologies Inc., Mallinckrodt plc, Leadiant Biosciences, Luminex Corporation, Bristol-Myers Squibb Company, CytImmune Sciences Inc., Nanobiotix, Starpharma Holdings Limited, Copernicus Therapeutics Inc., NanoCarrier Co. Ltd, LiPlasome Pharma ApS, Nami Therapeutics Corp., Nanospectra Biosciences Inc., Spago Nanomedical AB, Nanobiosym Inc., Nanoviricides Inc., Nanosys Inc., Nanocarrier Co. Ltd., Nanocyl SA, Nanogen Pvt. Ltd.

North America was the largest region in the healthcare nanotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the healthcare nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The healthcare nanotechnology market includes revenues earned by entities by targeting tumors, in drug delivery systems, and improving medical imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare Nanotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare nanotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for healthcare nanotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The healthcare nanotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease: Cardiovascular Diseases; Oncological Diseases; Neurological Diseases; Orthopedic Diseases; Infectious Diseases
  • 2) By Type: Organic; Inorganic; Carbon-Based
  • 3) By Application: Drug Delivery; Biomaterials; Active Implants; Tissue Regeneration
  • Subsegments:
  • 1) By Cardiovascular Diseases: Drug Delivery Systems; Diagnostic Imaging
  • 2) By Oncological Diseases: Targeted Drug delivery; Nanoparticle-Based Therapies; Imaging And Diagnostics
  • 3) By Neurological Diseases: Nanoparticle-Based Drug Delivery; Diagnostic Tools
  • 4) By Orthopedic Diseases: Bone regeneration And Repair; Drug Delivery Systems
  • 5) By Infectious Diseases: Antimicrobial Nanomaterials; Vaccine Delivery Systems
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; Abbott Laboratories; Merck & Company Inc.; Union Chimique Belge S. A; Teva Pharmaceutical Industries Ltd.; Sanofi SA; Taiwan Liposome Company Ltd.; GE Healthcare Technologies Inc.; Mallinckrodt plc; Leadiant Biosciences; Luminex Corporation; Bristol-Myers Squibb Company; CytImmune Sciences Inc.; Nanobiotix; Starpharma Holdings Limited; Copernicus Therapeutics Inc.; NanoCarrier Co. Ltd; LiPlasome Pharma ApS; Nami Therapeutics Corp.; Nanospectra Biosciences Inc.; Spago Nanomedical AB; Nanobiosym Inc.; Nanoviricides Inc.; Nanosys Inc.; Nanocarrier Co. Ltd.; Nanocyl SA; Nanogen Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Healthcare Nanotechnology Market Characteristics

3. Healthcare Nanotechnology Market Trends And Strategies

4. Healthcare Nanotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Healthcare Nanotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Healthcare Nanotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Healthcare Nanotechnology Market Growth Rate Analysis
  • 5.4. Global Healthcare Nanotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Healthcare Nanotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Healthcare Nanotechnology Total Addressable Market (TAM)

6. Healthcare Nanotechnology Market Segmentation

  • 6.1. Global Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Oncological Diseases
  • Neurological Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • 6.2. Global Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organic
  • Inorganic
  • Carbon-Based
  • 6.3. Global Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery
  • Biomaterials
  • Active Implants
  • Tissue Regeneration
  • 6.4. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Cardiovascular Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery Systems
  • Diagnostic Imaging
  • 6.5. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Oncological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Drug delivery
  • Nanoparticle-Based Therapies
  • Imaging And Diagnostics
  • 6.6. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Neurological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nanoparticle-Based Drug Delivery
  • Diagnostic Tools
  • 6.7. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Orthopedic Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone regeneration And Repair
  • Drug Delivery Systems
  • 6.8. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Infectious Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antimicrobial Nanomaterials
  • Vaccine Delivery Systems

7. Healthcare Nanotechnology Market Regional And Country Analysis

  • 7.1. Global Healthcare Nanotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Healthcare Nanotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Healthcare Nanotechnology Market

  • 8.1. Asia-Pacific Healthcare Nanotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Healthcare Nanotechnology Market

  • 9.1. China Healthcare Nanotechnology Market Overview
  • 9.2. China Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Healthcare Nanotechnology Market

  • 10.1. India Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Healthcare Nanotechnology Market

  • 11.1. Japan Healthcare Nanotechnology Market Overview
  • 11.2. Japan Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Healthcare Nanotechnology Market

  • 12.1. Australia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Healthcare Nanotechnology Market

  • 13.1. Indonesia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Healthcare Nanotechnology Market

  • 14.1. South Korea Healthcare Nanotechnology Market Overview
  • 14.2. South Korea Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Healthcare Nanotechnology Market

  • 15.1. Western Europe Healthcare Nanotechnology Market Overview
  • 15.2. Western Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Healthcare Nanotechnology Market

  • 16.1. UK Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Healthcare Nanotechnology Market

  • 17.1. Germany Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Healthcare Nanotechnology Market

  • 18.1. France Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Healthcare Nanotechnology Market

  • 19.1. Italy Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Healthcare Nanotechnology Market

  • 20.1. Spain Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Healthcare Nanotechnology Market

  • 21.1. Eastern Europe Healthcare Nanotechnology Market Overview
  • 21.2. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Healthcare Nanotechnology Market

  • 22.1. Russia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Healthcare Nanotechnology Market

  • 23.1. North America Healthcare Nanotechnology Market Overview
  • 23.2. North America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Healthcare Nanotechnology Market

  • 24.1. USA Healthcare Nanotechnology Market Overview
  • 24.2. USA Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Healthcare Nanotechnology Market

  • 25.1. Canada Healthcare Nanotechnology Market Overview
  • 25.2. Canada Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Healthcare Nanotechnology Market

  • 26.1. South America Healthcare Nanotechnology Market Overview
  • 26.2. South America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Healthcare Nanotechnology Market

  • 27.1. Brazil Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Healthcare Nanotechnology Market

  • 28.1. Middle East Healthcare Nanotechnology Market Overview
  • 28.2. Middle East Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Healthcare Nanotechnology Market

  • 29.1. Africa Healthcare Nanotechnology Market Overview
  • 29.2. Africa Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Healthcare Nanotechnology Market Competitive Landscape And Company Profiles

  • 30.1. Healthcare Nanotechnology Market Competitive Landscape
  • 30.2. Healthcare Nanotechnology Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

31. Healthcare Nanotechnology Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Ltd.
  • 31.2. Sanofi SA
  • 31.3. Taiwan Liposome Company Ltd.
  • 31.4. GE Healthcare Technologies Inc.
  • 31.5. Mallinckrodt plc
  • 31.6. Leadiant Biosciences
  • 31.7. Luminex Corporation
  • 31.8. Bristol-Myers Squibb Company
  • 31.9. CytImmune Sciences Inc.
  • 31.10. Nanobiotix
  • 31.11. Starpharma Holdings Limited
  • 31.12. Copernicus Therapeutics Inc.
  • 31.13. NanoCarrier Co. Ltd
  • 31.14. LiPlasome Pharma ApS
  • 31.15. Nami Therapeutics Corp.

32. Global Healthcare Nanotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Healthcare Nanotechnology Market

34. Recent Developments In The Healthcare Nanotechnology Market

35. Healthcare Nanotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 Healthcare Nanotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Healthcare Nanotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Healthcare Nanotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer